Arben Ventures

Arben Ventures operates as a venture capital firm, strategically investing in early-stage deep tech startups focused on human health. The firm provides pre-seed and seed-stage capital to founders leveraging scientific advancements to address significant challenges within healthcare domains. Their approach centers on identifying and supporting innovative ventures that are developing novel solutions in critical areas of global well-being.

Founded in 2022, Arben Ventures was established by a team of Stanford researchers, including Ariel Ganz. Their foundational insight stemmed from a recognition of the immense potential in nascent scientific and technological breakthroughs that lacked early-stage financial backing. The founders, with their deep academic and scientific pedigree, aimed to bridge this gap, committing to nurture ventures from their earliest conception.

Arben Ventures backs visionary founders and scientific teams who are building the future of health. The firm's long-term vision is to catalyze the creation of companies that will redefine healthcare, supporting innovations that ultimately lead to tangible improvements in human health outcomes. They aspire to invest in what they believe should exist, fostering its development until it becomes a reality.